Literature DB >> 32535589

Activation, Deficiency, and Reduced IFN-γ Production of Mucosal-Associated Invariant T Cells in Patients with Inflammatory Bowel Disease.

Jae Kyun Ju1, Young-Nan Cho2, Ki-Jeong Park2, Han Deok Kwak1, Hye-Mi Jin2, Seon-Young Park3, Hyun Soo Kim3, Seung-Jung Kee4, Yong-Wook Park5.   

Abstract

Mucosal-associated invariant T (MAIT) cells are innate-like T cells that can activate either in response to T-cell receptor (TCR) engagement or through activating cytokines and play an important role in autoimmune disorders. The study examined the level and function of MAIT cells in patients with inflammatory bowel disease (IBD). Circulating MAIT cell levels were significantly reduced in IBD patients. This MAIT cell deficiency was correlated with IBD disease activity grades, hemoglobin, and CRP. IFN-γ production of circulating MAIT cells in response to both MHC class 1b-like related protein (MR1)-dependent and -independent stimulations was decreased in IBD patients, which was partially associated with reduced activation of nuclear factor of activated T cells 1 (NFAT1) transcription factor, a main regulator of IFN-γ production. Expression levels of CD69, programmed death-1 (PD-1), and annexin V in MAIT cells were elevated in IBD patients. CCL20, CXCL10, CXCL16, and CCL25 were expressed higher in inflamed intestinal tissues than in noninflamed tissues. This study demonstrates that circulating MAIT cells are activated and numerically and functionally deficient in IBD patients. Furthermore, activated MAIT cells have the potential to migrate to inflamed tissues. These findings suggest an important role of MAIT cells in mucosal immunity in IBD.
© 2020 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Keywords:  Activation; Inflammatory bowel disease; Interferon-γ; Migration; Mucosal-associated invariant T cells

Mesh:

Substances:

Year:  2020        PMID: 32535589      PMCID: PMC7506267          DOI: 10.1159/000507931

Source DB:  PubMed          Journal:  J Innate Immun        ISSN: 1662-811X            Impact factor:   7.349


  51 in total

1.  Mucosal-associated invariant T (MAIT) cells are depleted and prone to apoptosis in cardiometabolic disorders.

Authors:  Sothea Touch; Karen E Assmann; Judith Aron-Wisnewsky; Florian Marquet; Christine Rouault; Magali Fradet; Héléna Mosbah; MetaCardis Consortium; Richard Isnard; Gérard Helft; Agnès Lehuen; Christine Poitou; Karine Clément; Sébastien André
Journal:  FASEB J       Date:  2018-04-27       Impact factor: 5.191

2.  Possible involvement of mucosal-associated invariant T cells in the progression of inflammatory bowel diseases.

Authors:  Kentaro Tominaga; Satoshi Yamagiwa; Toru Setsu; Naruhiro Kimura; Hiroki Honda; Hiroteru Kamimura; Yutaka Honda; Masaaki Takamura; Junji Yokoyama; Kenji Suzuki; Toshifumi Wakai; Shuji Terai
Journal:  Biomed Res       Date:  2017       Impact factor: 1.203

3.  Antimicrobial activity of mucosal-associated invariant T cells.

Authors:  Lionel Le Bourhis; Emmanuel Martin; Isabelle Péguillet; Amélie Guihot; Nathalie Froux; Maxime Coré; Eva Lévy; Mathilde Dusseaux; Vanina Meyssonnier; Virginie Premel; Charlotte Ngo; Béatrice Riteau; Livine Duban; Delphine Robert; Shouxiong Huang; Martin Rottman; Claire Soudais; Olivier Lantz
Journal:  Nat Immunol       Date:  2010-06-27       Impact factor: 25.606

4.  A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease.

Authors:  William J Sandborn; Brian G Feagan; Richard N Fedorak; Ellen Scherl; Mark R Fleisher; Seymour Katz; Jewel Johanns; Marion Blank; Paul Rutgeerts
Journal:  Gastroenterology       Date:  2008-07-17       Impact factor: 22.682

Review 5.  Innate and adaptive immunity in inflammatory bowel disease.

Authors:  Alessandra Geremia; Paolo Biancheri; Philip Allan; Gino R Corazza; Antonio Di Sabatino
Journal:  Autoimmun Rev       Date:  2013-06-15       Impact factor: 9.754

6.  Mucosal-associated invariant T-cell function is modulated by programmed death-1 signaling in patients with active tuberculosis.

Authors:  Jing Jiang; Xinjing Wang; Hongjuan An; Bingfen Yang; Zhihong Cao; Yanhua Liu; Jinwen Su; Fei Zhai; Ruo Wang; Guangyu Zhang; Xiaoxing Cheng
Journal:  Am J Respir Crit Care Med       Date:  2014-08-01       Impact factor: 21.405

7.  Mucosal-Associated Invariant T Cell Deficiency in Chronic Obstructive Pulmonary Disease.

Authors:  Yong Soo Kwon; Hye-Mi Jin; Young-Nan Cho; Moon-Ju Kim; Jeong-Hwa Kang; Hyun-Ju Jung; Ki-Jeong Park; Hae Jin Kee; Seung-Jung Kee; Yong-Wook Park
Journal:  COPD       Date:  2015-11-09       Impact factor: 2.409

8.  CD161+ MAIT cells are severely reduced in peripheral blood and lymph nodes of HIV-infected individuals independently of disease progression.

Authors:  Johanna Maria Eberhard; Philip Hartjen; Silke Kummer; Reinhold E Schmidt; Maximilian Bockhorn; Clara Lehmann; Ashwin Balagopal; Joachim Hauber; Jan van Lunzen; Julian Schulze zur Wiesch
Journal:  PLoS One       Date:  2014-11-04       Impact factor: 3.240

9.  Specific MAIT cell behaviour among innate-like T lymphocytes in critically ill patients with severe infections.

Authors:  David Grimaldi; Lionel Le Bourhis; Bertrand Sauneuf; Agnès Dechartres; Christophe Rousseau; Fatah Ouaaz; Maud Milder; Delphine Louis; Jean-Daniel Chiche; Jean-Paul Mira; Olivier Lantz; Frédéric Pène
Journal:  Intensive Care Med       Date:  2013-12-10       Impact factor: 17.440

10.  Activation, Impaired Tumor Necrosis Factor-α Production, and Deficiency of Circulating Mucosal-Associated Invariant T Cells in Patients with Scrub Typhus.

Authors:  Seung-Ji Kang; Hye-Mi Jin; Eun Jeong Won; Young-Nan Cho; Hyun-Ju Jung; Yong-Soo Kwon; Hae Jin Kee; Jae Kyun Ju; Jung-Chul Kim; Uh Jin Kim; Hee-Chang Jang; Sook-In Jung; Seung-Jung Kee; Yong-Wook Park
Journal:  PLoS Negl Trop Dis       Date:  2016-07-27
View more
  7 in total

1.  A Leak in the Dike.

Authors:  Arne Egesten; Heiko Herwald
Journal:  J Innate Immun       Date:  2020-08-20       Impact factor: 7.349

2.  Mucosal Associated Invariant T Cells Were Activated and Polarized Toward Th17 in Chronic Obstructive Pulmonary Disease.

Authors:  Wenjia Qiu; Ning Kang; Yanxu Wu; Yongjun Cai; Li Xiao; Haiyan Ge; Huili Zhu
Journal:  Front Immunol       Date:  2021-03-31       Impact factor: 7.561

Review 3.  Pathophysiological Roles of Mucosal-Associated Invariant T Cells in the Context of Gut Microbiota-Liver Axis.

Authors:  Yoseph Asmelash Gebru; Mi Ran Choi; Ganesan Raja; Haripriya Gupta; Satya Priya Sharma; Ye Rin Choi; Hyeong Seop Kim; Sang Jun Yoon; Dong Joon Kim; Ki Tae Suk
Journal:  Microorganisms       Date:  2021-02-01

4.  A Multi-Omics Analysis of Mucosal-Associated-Invariant T Cells Reveals Key Drivers of Distinct Modes of Activation.

Authors:  Kristin Schubert; Isabel Karkossa; Jana Schor; Beatrice Engelmann; Lisa Maria Steinheuer; Tony Bruns; Ulrike Rolle-Kampczyk; Jörg Hackermüller; Martin von Bergen
Journal:  Front Immunol       Date:  2021-05-24       Impact factor: 7.561

5.  The Study of Mucosal-Associated Invariant T Cells in Colon Cancer and Roles in Immune Activities.

Authors:  Juanfen Mo; Li Zheng; Zhenzhen Gao; Jiayuan Wu; Yi Bao
Journal:  Onco Targets Ther       Date:  2021-11-16       Impact factor: 4.147

6.  Mucosal-Associated Invariant T (MAIT) cells are highly activated in duodenal tissue of humans with Vibrio cholerae O1 infection: A preliminary report.

Authors:  Taufiqur R Bhuiyan; M Arifur Rahman; Shubhanshi Trivedi; Taliman Afroz; Hasan Al Banna; Mohammad Rubel Hoq; Ioana Pop; Owen Jensen; Rasheduzzaman Rashu; Muhammad Ikhtear Uddin; Motaher Hossain; Ashraful I Khan; Fahima Chowdhury; Jason B Harris; Stephen B Calderwood; Edward T Ryan; Firdausi Qadri; Daniel T Leung
Journal:  PLoS Negl Trop Dis       Date:  2022-05-12

Review 7.  MAIT Cells and Microbiota in Multiple Sclerosis and Other Autoimmune Diseases.

Authors:  Rosella Mechelli; Silvia Romano; Carmela Romano; Emanuele Morena; Maria Chiara Buscarinu; Rachele Bigi; Gianmarco Bellucci; Roberta Reniè; Giulia Pellicciari; Marco Salvetti; Giovanni Ristori
Journal:  Microorganisms       Date:  2021-05-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.